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population that does not have access to antiretrovirals have a 46-fold-increased risk of pneumococcal bacteremia, and, at some US medical centers, HIV-seropositive patients represented 40% of the cases of pneumococcal disease in adults [3] . Increasingly, antibiotic-resistant pediatric serogroups/serotypes cause invasive pneumococcal disease in adults [4] , particularly in individuals infected with HIV [5, 6] . The present study describes the influences that gender, HIV status, and age have on the incidence of antibiotic resistance and on infection with pediatric serogroups/serotypes of S. pneumoniae found in blood or cerebrospinal fluid of adults in Soweto and Johannesburg, South Africa.
Patients, materials, and methods. Cases studied were either culture-confirmed S. pneumoniae bacteremia or meningitis (at 3 urban hospitals, from 10 February 1996 to 22 December 2002). Data on 4046 patients were collected from (1) hospital databases at Baragwanath Hospital in Soweto and at Johannesburg Hospital in Johannesburg; (2) records, kept on paper, on 203 patients for a study at Hillbrow Hospital in Johannesburg during the same time period [2] ; and (3) an Epi Info 6 database of 255 patients, collected during 1996-1997 for a previous study conducted at Baragwanath Hospital [7] . These data were cross-referenced with blood-isolate data (consisting of serogroup/serotype and antibiotic-resistance information) from the Respiratory and Meningeal Research Unit of the National Institute for Communicable Diseases, in Johannesburg, to create complete records. Once duplicate patients and identifiers were removed, data on 3004 patients were available for analysis. Because of a lack of data on gender and/or age, 1152 patients were excluded from the present study; because of a lack of information on HIV status, another 830 patients were excluded. Thus, 1022 records of patients were used in the present study. Patients were divided into 2 age groups: those patients 18-39 years old and those patients у40 years old (range, 40-95 years); 11 adult patients whose specific ages were unknown were excluded from the age-group analysis. Both the study population and the excluded population had similar gender frequencies (48.5% women and 49.0% women, respectively) and similar HIV-seropositive prevalence frequencies (79.9% and 86.0%, respectively). There were more patients 18-39 years old in the excluded population (81.1%) than in the study population (69.4%). The prevalence of HIV-infected women in the excluded population (52.3%) was similar to that in the study population (51.9%), and the gender distribution among patients 18-39 years old in the excluded population (49.7% women) was similar to that in the study population (52.9% women). More Patients in the present study had S. pneumoniae cultured from either cerebrospinal fluid or blood. Blood was cultured by the BacTAlert automated blood-culture system (Organon Teknika); pneumococcal identification was confirmed on the basis of optochin sensitivity and bile solubility. Serotyping was performed by the Quellung method, with antiserum that was manufactured by the Statens Serum Institut. A patient with у2 separate episodes of infection was included in the present study more than once only if that individual's infections were due to different serogroups/serotypes. HIV status was confirmed by 2 of the following HIV ELISAs: Determine HIV-1/2 (Abbott GmbH); AxSYM system, HIV-1/2 (Abbott GmbH); Murex HIV 1 + 2 (Murex Diagnostic Limited); or Vitros Anti-HIV 1 + 2 (Ortho-Clinical Diagnostics). Antimicrobial-susceptibility testing was performed by Kirby Bauer disk-diffusion testing, with minimum inhibitory concentrations (MICs) confirmed by either broth microdilution, agar dilution, or E-test (AB Biodisk), according to the susceptibility criteria of the National Committee for Clinical Laboratory Standards [8] . Analyses were performed by Epi Info software (version 6.04d) (Centers for Disease Control and Prevention-World Health Organization) and by SAS software (version 9.00) (SAS Institute).
Results. Of the 1022 patients in the present study, 496 (48.5%) were women and 526 (52.5%) were men; 713 (69.8%) of them were 18-39 years old, and 817 (79.9%) of them were seropositive for HIV. Of the 496 women, 424 (85.5%) were seropositive for HIV; of the 526 men, 393 (74.7%) were seropositive for HIV (odds ratio [OR] ). P ! .001 Data on serogroups/serotypes were available for 878 of the patients. In men, serotype 1 was the most common (frequency, 21.9%), followed by serogroup 19 (frequency, 11.6%) and serogroup 6 (frequency, 10.3%); in women, serogroup 19 was the most common (frequency, 17.0%), followed by serotype 1 (frequency, 15.8%) and serogroup 6 (frequency, 11.9%). In HIVseronegative patients, serotype 1 was the most common (frequency, 37.4%), followed by serotype 3 (frequency, 12.7%) and serogroup 8 (frequency, 8.9%); in HIV-seropositive patients, serogroup 19 was the most common (frequency, 16.0%), followed by serotype 1 (frequency, 14.1%) and serogroup 6 (frequency, 11.9%). The distribution, by gender, of pediatric serogroups/serotypes is shown in table 1.
Data on penicillin susceptibility were available for 984 (96.3%) of the 1022 patients in the present study; 125 (12.7%) of these 984 were infected with an intermediately resistant strain, and 7 (0.7%) of them were infected with a fully resistant strain. Data on cotrimoxazole susceptibility were available for 882 of the patients; 87 (9.9%) of these 882 were infected with an intermediately resistant strain, and 180 (20.4%) of them were infected with a fully resistant strain. Data on clindamycin susceptibility were available for 835 of the patients; 38 (4.6%) of these 835 were infected with fully resistant strains. Data on erythromycin susceptibility were available for 982 of the patients; 44 (4.5%) of these 982 were infected with fully resistant strains. Data on rifampin susceptibility were available for 931 of the patients; 19 (2.0%) of these 931 were infected with fully resistant strains. The gender distribution of infection with nonsusceptible strains is shown in table 2. Of the 882 isolates that were tested for both penicillin and cotrimoxazole susceptibility, 91 (78.5%) of the 116 isolates that were nonsusceptible to penicillin were also nonsusceptible to cotrimoxazole (OR, 12.20 [95% CI, 7.39-20.27];
). P ! .001 A multivariable regression analysis was performed, and the possibility of colinearity between pediatric serogroup/serotype and penicillin resistance of S. pneumoniae was assessed. Because the condition index sum was !30, no colinearity was detected. Analyses were done in forward, backward, and stepwise fashion; all 3 methods resulted in the same model. When all other variables were controlled for, the following 4 factors were found Discussion. There are 90 serotypes of S. pneumoniae, which are categorized into 46 serogroups. In South African adults, serotype 1 has been the most-frequently isolated serotype [2] . However, whereas serotype 1 remains prevalent in the HIV-seronegative population, our study has revealed that serogroup 19 is now the most-prevalent serogroup in HIV-seropositive South African adults.
In 13 studies conducted in the United States during 1928-1998, the percentage of pneumococcal conjugate vaccine (PCV7) serotypes increased among adult isolates. Although PCV7 includes the usually susceptible serotypes 4 and 18C (which account for !5% of bacteremia in South African children [9] ), the increase in the United States was primarily due to the antibiotic-resistant pediatric serotypes 6B, 9V, 14, 19F, and 23F. At the same time, there was a decrease in the incidence of adult infections with epidemic adult serotypes 1-3 and 5 [4] .
Two previous, smaller studies (one with 457 subjects and one with 178 subjects) of this South African population have shown that infections with pediatric serogroups/serotypes occur more often in HIV-seropositive patients [5, 10] . Because HIV is now the dominant risk factor for pneumococcal bacteremia in Africa (among cases in the present study, for example, its frequency is close to 80%), we confirmed this finding and expanded it to determine the effect that gender, HIV infection, and age have on infection with pediatric serogroups/serotypes in adults. Our study demonstrates, for the first time, that pediatric serogroups/serotypes are isolated more frequently from HIV-seropositive women than from HIV-seropositive men.
Possible reasons for the increasing numbers of infections with pediatric serogroups/serotypes include (1) the loss of im-munity to these serogroups/serotypes in HIV-seropositive patients and (2) previous treatment with antibiotics, which can select for the resistant serogroups/serotypes [2, 5] . We have no evidence for changes in blood-culturing practices for adults in South Africa that may have influenced the distribution of serogroups/serotypes. Aging of the population may be important in the United States, because more people are living with chronic diseases that increase their risk of developing pneumococcal disease [4] ; however, on the basis of the findings of the present study, it can be said that the dominant factors in South Africa appear to be gender and HIV status.
Penicillin-nonsusceptible strains were found more often in women than in men, more often in HIV-seropositive patients than in HIV-seronegative patients, and more often in patients 18-39 years old than in those у40 years old; they also were found more often in HIV-seropositive women than in HIVseropositive men. An association was found between pediatric serogroups/serotypes and penicillin nonsusceptibility, with the pediatric serogroups/serotypes exhibiting most of the resistance in the present study. Not all of this association, however, could be explained by colinearity between penicillin resistance and pediatric serogroup/serotype.
The antibiotic resistance of S. pneumoniae continues to rise in South Africa, where resistance is higher in children than in adults [5, 9] . It is of interest that 18 of 19 rifampin-resistant strains were identified in HIV-infected individuals, a finding that possibly reflects an increased exposure of these patients to rifampin treatment for tuberculosis. The results of our analysis of cotrimoxazole resistance are similar to those of our analysis of penicillin resistance, confirming that cotrimoxazole use is an important risk factor for penicillin-nonsusceptible pneumococci in South Africa [11] .
Gender was associated with penicillin resistance and with infection with pediatric serogroups/serotypes. We attribute this increased risk to the fact that mothers frequently come into close contact with pediatric carriers of pneumococci. It has been shown that 26% of patients infected with penicillin-nonsusceptible S. pneumoniae are members of a household in which у1 member (excluding the patient) is attending a day-care center [12] ; that study suggested that women may have an increased risk of infection with penicillin-nonsusceptible strains (OR, 1.8 [95% CI, 0.6-5.4]), but the study was underpowered and so could not detect the association of such risk with gender, as did the present study. In another recent study, having a child !6 years old in day care was found to be a risk factor for the development of invasive pneumococcal disease (OR, 2.3 [95% CI, 1.3-4.1]) [13] , but there was no analysis of risk on the basis of the patients' gender. The possibility that child-to-parent transmission of pneumococci could occur also has been suggested by the concordance between the molecular fingerprints of antibiotic-resistant pneumococci carried by children and of invasive isolates from their parents [14] , but that study too did not report the parents' gender. It is likely that, within HIVinfected families, resistant pneumococci spread between child and parent. In this community, if children are the source of infection, there may be preferential child-to-mother transmission of resistant strains, because mothers may come into close contact with children more frequently than do fathers; and this pattern of transmission may be magnified if the mother is seropositive for HIV. The introduction of conjugate vaccine into the infant-immunization program in the United States has decreased invasive disease due to pediatric serogroups/serotypes in adults [15] ; this type of intervention may be particularly beneficial for the reduction of transmission of pneumococci from infants to their HIV-infected mothers.
The limitations of the present study include its retrospective design and the lack of information on age, gender, and HIV status of many patients. Because the prevalence, by gender, of infection with pediatric serogroups/serotypes was greater in the study population than in the excluded population, our results may overestimate this association; conversely, because the prevalence of penicillin-nonsusceptible strains was lower in the study population than in the excluded population, our results may underestimate this association. Our antibiotic-susceptibility analyses (except for those for both penicillin and cotrimoxazole resistance) may have been underpowered because of the low percentage of multiply resistant isolates identified. Thus, ORs and CIs were not available for all of these analyses. The excluded population had a slightly higher percentage of HIV infection than did the study population, so our results may even underestimate the burden of HIV infection in adults infected with S. pneumoniae.
The present study identifies significant associations (1) between the gender of adults and an increased incidence of antibiotic resistance and (2) between the gender of adults and infection with pediatric serogroups/serotypes of S. pneumoniae. The present study also highlights the increasing threat of antibiotic resistance and of infection with S. pneumoniae, especially in HIV-infected persons, both in South Africa and in many other countries where HIV infection is epidemic. We encourage the HIV testing and counseling of all patients with pneumococcal bacteremia. Future prospective studies should focus on analyses of specific risk factors, such as the risk of pneumococcal disease for an HIV-infected woman if she has children and the potential impact that PCV7 has on reduction of that risk. Our data suggest that interventions, such as PCV7, that reduce pneumococcal disease in both HIV-infected and -uninfected infants [16] and that prevent the transmission of pediatric serogroups/serotypes to adults [15] may reduce both antibiotic resistance and the burden of pneumococcal disease due to pediatric serotypes, particularly in young, HIV-infected women living in areas where HIV is the major risk factor for pneumococcal bacteremia.
